Advancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017 front page preview

Advancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017

DCU and UCD have jointly identified a compound purified from a marine species that exerts potent anti-inflammatory activity. The mechanism of action has been elucidated and the team have shown that the intracellular targ...

pdf 287KB

Enduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017 front page preview

Enduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017

Enduragel, which is an injectable hydrogel for the treatment of brain aneurysms and other vascular problems such as Arteriovenous Malformations (AVMs) and dural fistulas.

pdf 205.7KB

Novel Panel of Breast Cancer Biomarkers - Licensing Opportunity for Dublin City University - August 2017 front page preview

Novel Panel of Breast Cancer Biomarkers - Licensing Opportunity for Dublin City University - August 2017

We have identified a panel of serum biomarkers which when assayed along with CA15-3 can detect breast cancer in 90- 95% of cases tested. This is a major improvement over the existing CA 15-3 tests that are commercially a...

pdf 212.7KB

SEPTEC - Sepsis Detection Platform - Licensing Opportunity for Dublin City University - August 2017 front page preview

SEPTEC - Sepsis Detection Platform - Licensing Opportunity for Dublin City University - August 2017

SepTec is a centrifugal microfluidic disk platform. Antibody based electrochemical sensor technology, in conjunction with microfluidic engineering allows sensitive and rapid detection of pathogens in a 2mL whole blood sa...

pdf 258KB

Memsense - Lipid Bilayer Membrane Model Platform for Drug Discovery - Licensing Opportunity for Dublin City University - August 2017 front page preview

Memsense - Lipid Bilayer Membrane Model Platform for Drug Discovery - Licensing Opportunity for Dublin City University - August 2017

MemSense is an advanced true lipid bilayer membrane platform developed as a cell membrane model for application in pre-formulation studies of new molecules and drug delivery vehicles in drug discovery in the pharmaceutic...

pdf 274.3KB